QuVa Pharma, Inc. recalls fentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.1% 100 mg/100 mL (1 mg/mL) in 0.9% Sodium Chloride 100 mL CADD Pres
Recalled December 11, 2019 · FDA recall D-0559-2020 · QuVa Pharma
Hazard
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules · FDA Class II
Sold at
Nationwide.
Description
Presence of Particulate matter: manufacturer recalled fentanyl API due to potential for glass particules
Product
fentaNYL 200 mcg/100 mL (2 mcg/mL) BUPivacaine HCl 0.1% 100 mg/100 mL (1 mg/mL) in 0.9% Sodium Chloride 100 mL CADD Preservative Free, Rx, QuVA Pharma 1075 West Park One Drive, Suite 100 Sugar Land, TX 77478 NDC 70092-1255-75
Manufacturer(s)
QuVa Pharma, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →